The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia -- Volume II: Technical Report
Download full text from publisher
Other versions of this item:
- Paul V. Grootendorst & Lisa R. Dolovich & Anne M. Holbrook & Adrian R. Levy & Bernie J. O'Brien, 2002. "The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia--Volume II: Technical Report," Social and Economic Dimensions of an Aging Population Research Papers 71, McMaster University.
More about this item
Keywordsreference pricing; prescription drugs; ACE inhibitors; calcium channel blockers; nitrates; pharmaceutical cost control; seniors; user fees;
- I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
NEP fieldsThis paper has been announced in the following NEP Reports:
- NEP-ALL-2002-11-18 (All new papers)
StatisticsAccess and download statistics
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:mcm:qseprr:370. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (). General contact details of provider: http://edirc.repec.org/data/demcmca.html .
We have no references for this item. You can help adding them by using this form .